Literature DB >> 20688412

Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses.

Sandy Pelletier1, Christian Drouin, Nathalie Bédard, Salim I Khakoo, Julie Bruneau, Naglaa H Shoukry.   

Abstract

BACKGROUND & AIMS: Natural killer (NK) cells provide early defense against viral infections by killing infected cells and producing cytokines that inhibit viral replication. NK cells also interact with dendritic cells (DCs) and this reciprocal interaction regulates both innate and adaptive immunity. Genetic studies have suggested that NK cell activity is a determinant of HCV infectious outcome but a functional correlation has not been established. We hypothesized that increased NK cell activity during acute HCV infection correlates with spontaneous viral clearance.
METHODS: We used multiparametric flow cytometry to monitor longitudinally the phenotype and the activity of NK cells in a cohort of intravenous drug users following HCV exposure. Three groups were studied: acute HCV with chronic evolution (n = 13), acute resolving HCV (n = 11), and exposed un-infected individuals (n = 10). We examined the expression of several NK cell-activating and -inhibiting receptors, IFN-γ production and CD107a degranulation upon stimulation, and the kinetics of NK cell responses relative to T cell responses.
RESULTS: We observed decreased expression of the inhibitory NKG2A receptor in NK cells following spontaneous HCV clearance. In addition, we observed increased NK cell degranulation during acute HCV irrespective of infectious outcome. NK cell peak responses preceded or coincided with peak T cell responses. Furthermore, NK cell degranulation correlated with the magnitude of HCV-specific T cells.
CONCLUSIONS: Our results demonstrate that NK cells are activated during acute HCV regardless of infection outcome and may play an indirect role through induction and priming of T cell responses.
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688412      PMCID: PMC4178223          DOI: 10.1016/j.jhep.2010.05.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  49 in total

1.  Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection.

Authors:  J Corado; F Toro; H Rivera; N E Bianco; L Deibis; J B De Sanctis
Journal:  Clin Exp Immunol       Date:  1997-09       Impact factor: 4.330

2.  Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.

Authors:  Masahisa Jinushi; Tetsuo Takehara; Tomohide Tatsumi; Tatsuya Kanto; Takuya Miyagi; Takahiro Suzuki; Yoshiyuki Kanazawa; Naoki Hiramatsu; Norio Hayashi
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

Review 3.  Cellular and molecular mechanisms of liver tolerance.

Authors:  Ian N Crispe; Matthew Giannandrea; Ingo Klein; Beena John; Bradford Sampson; Sherry Wuensch
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 4.  Effector and regulatory events during natural killer-dendritic cell interactions.

Authors:  Lorenzo Moretta; Guido Ferlazzo; Cristina Bottino; Massimo Vitale; Daniela Pende; Maria Cristina Mingari; Alessandro Moretta
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

5.  Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients.

Authors:  Andrea De Maria; Manuela Fogli; Stefania Mazza; Monica Basso; Antonio Picciotto; Paola Costa; Sonia Congia; Maria Cristina Mingari; Lorenzo Moretta
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

6.  Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients.

Authors:  D M Novick; M Ochshorn; V Ghali; T S Croxson; W D Mercer; N Chiorazzi; M J Kreek
Journal:  J Pharmacol Exp Ther       Date:  1989-08       Impact factor: 4.030

7.  CD107a as a functional marker for the identification of natural killer cell activity.

Authors:  Galit Alter; Jessica M Malenfant; Marcus Altfeld
Journal:  J Immunol Methods       Date:  2004-11       Impact factor: 2.303

Review 8.  Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy.

Authors:  Kenneth E Ugen; Susan B Nyland
Journal:  Springer Semin Immunopathol       Date:  2006-10-13

9.  Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis.

Authors:  M J Robertson; M A Caligiuri; T J Manley; H Levine; J Ritz
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

10.  Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design.

Authors:  Susan Smyk-Pearson; Ian A Tester; Dennis Lezotte; Anna W Sasaki; David M Lewinsohn; Hugo R Rosen
Journal:  J Infect Dis       Date:  2006-07-12       Impact factor: 5.226

View more
  48 in total

1.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

2.  The 3rd Canadian Symposium on Hepatitis C Virus: expanding care in the interferon-free era.

Authors:  Sonya A MacParland; Marc Bilodeau; Jason Grebely; Julie Bruneau; Curtis Cooper; Marina Klein; Selena Sagan; Norma Choucha; Louise Balfour; Frank Bialystok; Mel Krajden; Jennifer Raven; Eve Roberts; Rodney Russell; Michael Houghton; D Lorne Tyrrell; Jordan J Feld
Journal:  Can J Gastroenterol Hepatol       Date:  2014-10

Review 3.  Organ system view of the hepatic innate immunity in HCV infection.

Authors:  Bo-Ram Bang; Sandra Elmasry; Takeshi Saito
Journal:  J Med Virol       Date:  2016-05-13       Impact factor: 2.327

4.  Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.

Authors:  Cordelia Manickam; Premeela Rajakumar; Lynn Wachtman; Joshua A Kramer; Amanda J Martinot; Valerie Varner; Luis D Giavedoni; R Keith Reeves
Journal:  J Virol       Date:  2016-09-29       Impact factor: 5.103

5.  Natural killer and natural killer T cells in liver fibrosis.

Authors:  Bin Gao; Svetlana Radaeva
Journal:  Biochim Biophys Acta       Date:  2012-09-26

Review 6.  Natural killer cell responses during viral infections: flexibility and conditioning of innate immunity by experience.

Authors:  Silvia M Vidal; Salim I Khakoo; Christine A Biron
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

Review 7.  Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin.

Authors:  Bassem Refaat; Adel Galal El-Shemi; Ahmed Ashshi; Esam Azhar
Journal:  Int J Clin Exp Med       Date:  2015-07-15

8.  Reduced frequencies of NKp30+NKp46+, CD161+, and NKG2D+ NK cells in acute HCV infection may predict viral clearance.

Authors:  Galit Alter; Stephanie Jost; Suzannah Rihn; Laura L Reyor; Brian E Nolan; Musie Ghebremichael; Ronald Bosch; Marcus Altfeld; Georg M Lauer
Journal:  J Hepatol       Date:  2010-12-17       Impact factor: 25.083

9.  Long-term effect on natural killer cells by interferon-α therapy on the outcomes of HCV infection.

Authors:  Xiaoli Hu; Yanfang Jiang; Xiurong Li; Yanhang Gao; Xiaoli Guo; Xiumei Chi; Hongqing Yan; Junyan Feng; Jin Zhong; Bing Sun; Xue Shao; Weihua Xiao; Yu Pan; Junqi Niu
Journal:  J Interferon Cytokine Res       Date:  2013-12-24       Impact factor: 2.607

Review 10.  Innate and Adaptive Immune Responses in Chronic HCV Infection.

Authors:  Lynn B Dustin
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.